Cargando…

Myostatin: A Skeletal Muscle Chalone

Myostatin (GDF-8) was discovered 25 years ago as a new transforming growth factor-β family member that acts as a master regulator of skeletal muscle mass. Myostatin is made by skeletal myofibers, circulates in the blood, and acts back on myofibers to limit growth. Myostatin appears to have all of th...

Descripción completa

Detalles Bibliográficos
Autor principal: Lee, Se-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163667/
https://www.ncbi.nlm.nih.gov/pubmed/36266260
http://dx.doi.org/10.1146/annurev-physiol-012422-112116
_version_ 1785037931207983104
author Lee, Se-Jin
author_facet Lee, Se-Jin
author_sort Lee, Se-Jin
collection PubMed
description Myostatin (GDF-8) was discovered 25 years ago as a new transforming growth factor-β family member that acts as a master regulator of skeletal muscle mass. Myostatin is made by skeletal myofibers, circulates in the blood, and acts back on myofibers to limit growth. Myostatin appears to have all of the salient properties of a chalone, which is a term proposed over a half century ago to describe hypothetical circulating, tissue-specific growth inhibitors that control tissue size. The elucidation of the molecular, cellular, and physiological mechanisms underlying myostatin activity suggests that myostatin functions as a negative feedback regulator of muscle mass and raises the question as to whether this type of chalone mechanism is unique to skeletal muscle or whether it also operates in other tissues.
format Online
Article
Text
id pubmed-10163667
institution National Center for Biotechnology Information
language English
publishDate 2023
record_format MEDLINE/PubMed
spelling pubmed-101636672023-05-06 Myostatin: A Skeletal Muscle Chalone Lee, Se-Jin Annu Rev Physiol Article Myostatin (GDF-8) was discovered 25 years ago as a new transforming growth factor-β family member that acts as a master regulator of skeletal muscle mass. Myostatin is made by skeletal myofibers, circulates in the blood, and acts back on myofibers to limit growth. Myostatin appears to have all of the salient properties of a chalone, which is a term proposed over a half century ago to describe hypothetical circulating, tissue-specific growth inhibitors that control tissue size. The elucidation of the molecular, cellular, and physiological mechanisms underlying myostatin activity suggests that myostatin functions as a negative feedback regulator of muscle mass and raises the question as to whether this type of chalone mechanism is unique to skeletal muscle or whether it also operates in other tissues. 2023-02-10 2022-10-20 /pmc/articles/PMC10163667/ /pubmed/36266260 http://dx.doi.org/10.1146/annurev-physiol-012422-112116 Text en https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. See credit lines of images or other third-party material in this article for license information.
spellingShingle Article
Lee, Se-Jin
Myostatin: A Skeletal Muscle Chalone
title Myostatin: A Skeletal Muscle Chalone
title_full Myostatin: A Skeletal Muscle Chalone
title_fullStr Myostatin: A Skeletal Muscle Chalone
title_full_unstemmed Myostatin: A Skeletal Muscle Chalone
title_short Myostatin: A Skeletal Muscle Chalone
title_sort myostatin: a skeletal muscle chalone
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163667/
https://www.ncbi.nlm.nih.gov/pubmed/36266260
http://dx.doi.org/10.1146/annurev-physiol-012422-112116
work_keys_str_mv AT leesejin myostatinaskeletalmusclechalone